S065-0147 Screening compound: N-CYCLOPENTYL-N'-{1-[6-(1-PYRROLIDINYL)-4-PYRIMIDINYL]-3-PIPERIDYL}UREA

S065-0147 Screening compound: N-CYCLOPENTYL-N'-{1-[6-(1-PYRROLIDINYL)-4-PYRIMIDINYL]-3-PIPERIDYL}UREA
S065-0147 Screening compound: N-CYCLOPENTYL-N'-{1-[6-(1-PYRROLIDINYL)-4-PYRIMIDINYL]-3-PIPERIDYL}UREA alternative view

Chemical Structure Depiction of ChemDiv screening compound S065-0147
N-CYCLOPENTYL-N'-{1-[6-(1-PYRROLIDINYL)-4-PYRIMIDINYL]-3-PIPERIDYL}UREA

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S065-0147

Molecular Formula

C19H30N6O (C19 H30 N6 O)

Compound Name

N-CYCLOPENTYL-N'-{1-[6-(1-PYRROLIDINYL)-4-PYRIMIDINYL]-3-PIPERIDYL}UREA

IUPAC name

3-cyclopentyl-1-{1-[6-(pyrrolidin-1-yl)pyrimidin-4-yl]piperidin-3-yl}urea

SMILES

O=C(NC1CCCC1)NC(CCC1)CN1c1ncnc(N2CCCC2)c1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

358.49

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.418

Distribution Coefficient, logD

3.417

Water Solubility, LogSw

-3.68

Polar Surface Area

60.751

Acid Dissociation Constant (pKa)

16.56

Base Dissociation Constant (pKb)

4.84

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

73.68

S065-0147 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
Agro:
  • Agro

References: we are preparing a list of scientific research reports with S065-0147 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S065-0147?
Check Price and Availability of S065-0147, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S065-0147 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S065-0147
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S065-0147
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S065-0147 available by request